GlassScriptPhysician profile
Michael P Basista
NPI 1639112501
$633.38
in general payments reported to CMS, 2019-2025
11 companies · $36.90 in 2025
The $36.90 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.43 · 2020: $154 · 2021: $256 · 2022: $103 · 2024: $32.12 · 2025: $36.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.02 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $216.89 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $200.03 | 2019-2022 | |
| Pfizer INC. | $46.90 | 2021-2025 | |
| Genentech USA, INC. | $40.79 | 2020-2022 | |
| Glaxosmithkline, LLC. | $27.73 | 2021 | |
| Seqirus USA INC | $20.97 | 2019 | |
| Eko Health, INC. | $20.00 | 2025 | |
| Abbvie INC. | $16.43 | 2024 | |
| Allergan, INC. | $16.01 | 2019 | |
| Exact Sciences Corporation | $15.69 | 2024 | Cologuard Collection Kit |
| Redhill Biopharma INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Basista listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.